Inny tytuł:

The pharmaceutical industry, innovation, generics and competitiveness in the context of EU Enlargement

Wydawca:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Abstrakt:

The market of medicines in new members of European Union with population of 75 million people totaled in € 7 billions. The product patents were implemented during 1990’s in these countries. Patent protection is a key concern for research - based industry in unified market. In central and Eastern European markets the generics make about 70% of all medicines prescribed. The novelty on the market are “authorized generics”.

Czasopismo/Seria/cykl:

Biotechnologia, vol.76, 1 (2007)-.

Tom:

76

Zeszyt:

1

Strona pocz.:

176

Strona końc.:

185

Szczegółowy typ zasobu:

Article

Format:

application/pdf

Identyfikator zasobu:

0860-7796 ; oai:rcin.org.pl:87166 ; IChB B-72

Źródło:

Library of Institute of Bioorganic Chemistry PAS

Język:

pol

Język streszczenia:

eng

Zakres czasowy:

1988-2010

Prawa:

Creative Commons Attribution BY-SA 4.0 license

Zasady wykorzystania:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitalizacja:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Lokalizacja oryginału:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Dofinansowane ze środków:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Dostęp:

Open